Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic …
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Black Diamond Therapeutics, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. | FMP | High | United States | Redwood City | |
| Alector, Inc. | FMP | High | United States | South San Francisco | |
| Passage Bio, Inc. | FMP | High | United States | Philadelphia | |
| Homology Medicines, Inc. | FMP | High | United States | Bedford | |
| Atreca, Inc. | FMP | High | United States | South San Francisco | |
| TCR2 Therapeutics Inc. | FMP | High | United States | Cambridge | |
| Harpoon Therapeutics, Inc. | FMP | High | United States | South San Francisco | |
| Stoke Therapeutics, Inc. | FMP | High | United States | Bedford |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |